Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Abdominal Radiology
Erschienen in: Abdominal Radiology 7/2015

01.10.2015 | Pictorial Essay

FDG PET–CT of gynecologic cancers: pearls and pitfalls

verfasst von: Hima B. Prabhakar, Jessica J. Kraeft, John O. Schorge, James A. Scott, Susanna I. Lee

Erschienen in: Abdominal Radiology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

FDG PET–CT plays an important role in treatment planning and in prognosis assessment of gynecologic cancer patients. Detection of hypermetabolic tissue with FDG PET, when combined with the high spatial resolution of CT, results in improved cancer detection and localization not afforded by either modality independently. This article is a primer for a radiologist performing PET–CT on gynecologic cancer patients and includes the imaging protocol, normal pattern of FDG distribution in the female pelvis and the lymph node drainage pathways from the gynecologic organs. Clinically relevant imaging findings that should be included in the report are discussed. Case examples illustrate how potential errors in exam interpretation can be avoided by concurrently performing a high-quality diagnostic CT with the FDG PET scan and by analyzing both the stand-alone and the fusion images.
Literatur
1.
Gorospe L, Raman S, Echeveste J, et al. (2005) Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun 26(8):671–687CrossRefPubMed
2.
Gorospe L, Jover-Diaz R, Vicente-Bartulos A (2012) Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies. Abdom Imaging 37(6):1041–1065CrossRefPubMed
3.
Rahmim A, Zaidi H (2008) PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun 29(3):193–207CrossRefPubMed
4.
Surasi DS, Bhambhvani P, Baldwin JA, Almodovar SE, O’Malley JP (2014) (1)(8)F-FDG PET and PET/CT patient preparation: a review of the literature. J Nucl Med Technol 42(1):5–13CrossRefPubMed
5.
Cronin CG, Prakash P, Blake MA (2010) Oral and IV contrast agents for the CT portion of PET/CT. AJR Am J Roentgenol 195(1):W5–W13CrossRefPubMed
6.
Pfannenberg AC, Aschoff P, Brechtel K, et al. (2007) Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging. Br J Radiol 80(954):437–445CrossRefPubMed
7.
Kitajima K, Suzuki K, Senda M, et al. (2011) Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone? Ann Nucl Med 25(7):511–519CrossRefPubMed
8.
Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF (2004) To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med 45(Suppl 1):56s–65sPubMed
9.
Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA (2007) Bowel hot spots at PET-CT. Radiographics 27(1):145–159CrossRefPubMed
10.
Kitajima K, Murakami K, Kaji Y, Sugimura K (2010) Spectrum of FDG PET/CT findings of uterine tumors. AJR Am J Roentgenol 195(3):737–743CrossRefPubMed
11.
Liu Y (2009) Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls. Ann Nucl Med 23(2):107–112CrossRefPubMed
12.
Zhu Z, Wang B, Cheng W, et al. (2006) Endometrial and ovarian F-18 FDG uptake in serial PET studies and the value of delayed imaging for differentiation. Clin Nucl Med 31(12):781–787CrossRefPubMed
13.
Lerman H, Metser U, Grisaru D, et al. (2004) Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 45(2):266–271PubMed
14.
Chura JC, Truskinovsky AM, Judson PL, et al. (2007) Positron emission tomography and leiomyomas: clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review. Gynecol Oncol 104(1):247–252CrossRefPubMed
15.
Kao CH (2003) FDG uptake in a huge uterine myoma. Clin Nucl Med 28(3):249PubMed
16.
Ames J, Blodgett T, Meltzer C (2005) 18F-FDG uptake in an ovary containing a hemorrhagic corpus luteal cyst: false-positive PET/CT in a patient with cervical carcinoma. AJR Am J Roentgenol 185(4):1057–1059CrossRefPubMed
17.
Bagga S (2007) A corpus luteal cyst masquerading as a lymph node mass on PET/CT scan in a pregnant woman with an anterior mediastinal lymphomatous mass. Clin Nucl Med 32(8):649–651CrossRefPubMed
18.
Hricak H, Gatsonis C, Chi DS, et al. (2005) Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 23(36):9329–9337CrossRefPubMed
19.
Connor JP, Andrews JI, Anderson B, Buller RE (2000) Computed tomography in endometrial carcinoma. Obstet Gynecol 95(5):692–696CrossRefPubMed
20.
Sironi S, Buda A, Picchio M, et al. (2006) Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 238(1):272–279CrossRefPubMed
21.
Antonsen SL, Jensen LN, Loft A, et al. (2013) MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer—a multicenter prospective comparative study. Gynecol Oncol 128(2):300–308CrossRefPubMed
22.
Cohn DE, Dehdashti F, Gibb RK, et al. (2002) Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 85(1):179–184CrossRefPubMed
23.
Brown G, Richards CJ, Bourne MW, et al. (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227(2):371–377CrossRefPubMed
24.
Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105(2):103–104CrossRefPubMed
25.
Koh WJ, Greer BE, Abu-Rustum NR, et al. (2013) Cervical cancer. J Natl Compr Cancer Netw 11(3):320–343
26.
Tirumani SH, Shanbhogue AK, Prasad SR (2013) Current concepts in the diagnosis and management of endometrial and cervical carcinomas. Radiol Clin N Am 51(6):1087–1110CrossRefPubMed
27.
Barter JF, Soong SJ, Shingleton HM, Hatch KD, Orr JW Jr (1989) Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 32(3):292–296CrossRefPubMed
28.
Fiorica JV, Roberts WS, Greenberg H, et al. (1990) Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 36(3):343–347CrossRefPubMed
29.
Pandharipande PV, Choy G, del Carmen MG, et al. (2009) MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes. AJR Am J Roentgenol 192(3):802–814CrossRefPubMed
30.
Stehman FB, Bundy BN, DiSaia PJ, et al. (1991) Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67(11):2776–2785CrossRefPubMed
31.
Patel CN, Nazir SA, Khan Z, Gleeson FV, Bradley KM (2011) 18F-FDG PET/CT of Cervical Carcinoma. Am J Roentgenol 196(5):1225–1233CrossRef
32.
Choi HJ, Roh JW, Seo SS, et al. (2006) Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 106(4):914–922CrossRefPubMed
33.
Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I (2004) Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol 22(11):2167–2171CrossRefPubMed
34.
Koh WJ, Greer BE, Abu-Rustum NR, et al. (2014) Uterine neoplasms, version 1.2014. J Natl Compr Cancer Netw 12(2):248–280
35.
Mariani A, Dowdy SC, Cliby WA, et al. (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109(1):11–18PubMedCentralCrossRefPubMed
36.
Frei KA, Kinkel K (2001) Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 13(6):850–855CrossRefPubMed
37.
Signorelli M, Guerra L, Buda A, et al. (2009) Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases. Gynecol Oncol 115(2):231–235CrossRefPubMed
38.
Picchio M, Mangili G, Samanes Gajate AM, et al. (2010) High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging. Nucl Med Commun 31(6):506–512PubMed
39.
Amit A, Schink J, Reiss A, Lowenstein L (2011) PET/CT in gynecologic cancer: present applications and future prospects—a clinician’s perspective. Obstet Gynecol Clin N Am 38(1):1–21 (vii)CrossRef
40.
Hricak H, Mendelson E, Bohm-Velez M, et al. (2000) Endometrial cancer of the uterus. American College of Radiology. ACR Appropriateness Criteria. Radiology 215(Suppl):947–953PubMed
41.
Mutch DG, Prat J (2014) 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol 133(3):401–404CrossRefPubMed
42.
Morgan RJ Jr, Alvarez RD, Armstrong DK, et al. (2013) Ovarian cancer, version 2.2013. J Natl Compr Cancer Netw 11(10):1199–1209
43.
Sebastian S, Lee SI, Horowitz NS, et al. (2008) PET-CT vs. CT alone in ovarian cancer recurrence. Abdom Imaging 33(1):112–118CrossRefPubMed
44.
Mitchell DG, Javitt MC, Glanc P, et al. (2013) ACR appropriateness criteria staging and follow-up of ovarian cancer. J Am Coll Radiol 10(11):822–827CrossRefPubMed
45.
Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50(Suppl 1):11s–20sCrossRefPubMed
46.
Kapoor V, McCook BM, Torok FS (2004) An introduction to PET-CT imaging. Radiographics 24(2):523–543CrossRefPubMed
47.
Brechtel K, Klein M, Vogel M, et al. (2006) Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging. J Nucl Med 47(3):470–476PubMed
48.
Blake MA, Singh A, Setty BN, et al. (2006) Pearls and pitfalls in interpretation of abdominal and pelvic PET-CT. Radiographics 26(5):1335–1353CrossRefPubMed
49.
Chen YW, Huang MY, Hou PN, et al. (2009) FDG PET/CT delayed diuretic imaging technique for differentiating invasive pelvic cancer. Clin Nucl Med 34(4):233–235CrossRefPubMed
50.
Koyama K, Okamura T, Kawabe J, et al. (2003) Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors. J Nucl Med 44(3):353–358PubMed
Metadaten
Titel
FDG PET–CT of gynecologic cancers: pearls and pitfalls
verfasst von
Hima B. Prabhakar
Jessica J. Kraeft
John O. Schorge
James A. Scott
Susanna I. Lee
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 7/2015
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0362-7

Weitere Artikel der Ausgabe 7/2015

Abdominal Radiology 7/2015 Zur Ausgabe

Pictorial Essay

Brachytherapy in pelvic malignancies: a review for radiologists

Classics in Abdominal Imaging

Coffee bean sign

OriginalPaper

The shading sign: is it exclusive of endometriomas?

OriginalPaper

Assessing splenic enlargement on CT by unidimensional measurement changes in patients with colorectal liver metastases

Classics in Abdominal Imaging

The “jackstone” appearance

OriginalPaper

Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease

Neu im Fachgebiet Radiologie

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise